| Literature DB >> 27070779 |
Zongtao Lin1, Srinivasa R Marepally1, Dejian Ma1, Tae-Kang Kim2, Allen Sw Oak2, Linda K Myers3, Robert C Tuckey4, Andrzej T Slominski2,5, Duane D Miller1, Wei Li1.
Abstract
The vitamin D3 metabolite, 20S,23S-dihydroxyvitamin D3, was chemically synthesized for the first time and identified to be the same as the enzymatically produced metabolite. The C23 absolute configurations of both 20S,23S/R-dihydroxyvitamin D3 epimers were unambiguously assigned by NMR and Mosher ester analysis. Their kinetics of CYP27B1 metabolism were investigated during the production of their 1α-hydroxylated derivatives. Bioactivities of these products were compared in terms of vitamin D3 receptor activation, anti-inflammatory, and antiproliferative activities.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27070779 PMCID: PMC5330258 DOI: 10.1021/acs.jmedchem.6b00182
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446